Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors Kasi P, Fehringer G, Taniguchi H, et al. JCO-PO. 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen